These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 34453603

  • 1. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA, Soliman TT, Abousaif WS, Shebl AA.
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S, Agrawal D.
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q, Tang J, Han Y, Wang D, Ye H.
    Ophthalmic Res; 2018 Nov; 59(3):126-134. PubMed ID: 28803239
    [Abstract] [Full Text] [Related]

  • 4. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P.
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C, Singh H, Jain AK, Gupta A, Ram J.
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY.
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M, Abou Samra W, Ghoneim E.
    Med Hypothesis Discov Innov Ophthalmol; 2022 Aug; 11(2):52-63. PubMed ID: 37641784
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
    Caputo R, Marziali E, de Libero C, Di Grande L, Danti G, Virgili G, Villani E, Mori F, Bacci GM, Lucenteforte E, Pucci N.
    Cornea; 2021 Nov 01; 40(11):1395-1401. PubMed ID: 34029239
    [Abstract] [Full Text] [Related]

  • 13. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK, Pawar N, Ravindran M, Allapitchai F, Rengappa R.
    J AAPOS; 2019 Feb 01; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [Abstract] [Full Text] [Related]

  • 14. When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol.
    Arnon R, Rozen-Knisbacher I, Yahalomi T, Stanescu N, Niazov Y, Goldberg D, Sharabi-Nov A, Mostovoy D.
    Int Ophthalmol; 2022 Jun 01; 42(6):1771-1780. PubMed ID: 34981294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P, Vichyanond P, Wongsawad W.
    Asian Pac J Allergy Immunol; 2003 Mar 01; 21(1):25-30. PubMed ID: 12931748
    [Abstract] [Full Text] [Related]

  • 17. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P, Kosrirukvongs P.
    Curr Allergy Asthma Rep; 2013 Jun 01; 13(3):308-14. PubMed ID: 23625179
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G, Ghiglioni DG, Cozzi L, Osnaghi S, Viola F, Marchisio P.
    Clin Rev Allergy Immunol; 2023 Aug 01; 65(2):277-329. PubMed ID: 37658939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.